Skip to main navigation
Skip to search
Skip to main content
University of Toyama Home
日本語
English
Home
Profiles
Research units
Projects
Research output
Datasets
Prizes
Activities
Courses
Search by expertise, name or affiliation
Adalimumab monotherapy and a combination with azathioprine for Crohn's disease: A prospective, randomized trial
DIAMOND study group
Internal Medicine (3)
Research output
:
Contribution to journal
›
Article
›
peer-review
213
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Adalimumab monotherapy and a combination with azathioprine for Crohn's disease: A prospective, randomized trial'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adalimumab
100%
Crohn's Disease
100%
Prospective Randomized Trial
100%
Monotherapy
100%
Nave
25%
Clinical Efficacy
12%
Subcutaneous Administration
12%
Clinical Remission
12%
Remission Rate
12%
Non-responders
12%
Thiopurines
12%
Active Crohn's Disease
12%
Imputation Analysis
12%
Active Disease
12%
Endoscopic Improvement
12%
Pharmacology, Toxicology and Pharmaceutical Science
Azathioprine
100%
Monotherapy
100%
Crohn's Disease
100%
Adalimumab
100%
Remission
25%
Disease
12%
Side Effect
12%
Subcutaneous Injection
12%
Prospective Study
12%
Biological Product
12%
Mercaptopurine
12%
Neuroscience
Azathioprine
100%
Adalimumab
100%
Mercaptopurine
14%